RecruitingNCT03192774
The Prospective Segeberg TAVI Registry
A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg
Sponsor
Segeberger Kliniken GmbH
Enrollment
2,000 participants
Start Date
Sep 1, 2007
Study Type
OBSERVATIONAL
Conditions
Summary
A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Transcatheter Aortic Valve Implantation for people with aortic valve stenosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICETranscatheter Aortic Valve Implantation
Interventional replacement of the aortic valve
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03192774
Related Trials
CHATEAU Registry: Clinical Outcomes After Transcatheter Aortic Valve Replacement
NCT077098581 location
Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation
NCT075666241 location
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
NCT0567283631 locations
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT072767113 locations
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
NCT0655779871 locations